HUM Deadline: HUM Investors Have Opportunity to Lead Humana Inc. Securities Fraud Lawsuit

Group 1 - A class action lawsuit has been filed against Humana Inc. on behalf of shareholders who purchased common stock between July 27, 2022, and January 24, 2024, with a deadline for lead plaintiff motions set for August 2, 2024 [1][3] - The lawsuit alleges that Humana misled investors regarding its business operations, specifically downplaying pressures on adjusted earnings per share (EPS) due to increased medical costs from pent-up demand for healthcare procedures [2][5] - The lawsuit claims that when the true details about Humana's financial pressures became public, investors suffered damages [5] Group 2 - The Rosen Law Firm is investigating allegations that Humana made false and misleading statements and failed to disclose material adverse facts about its business [2][5] - Shareholders can join the class action without participating in the case, remaining as absent class members if they choose [3][6] - All representation in the lawsuit is on a contingency fee basis, meaning shareholders pay no fees or expenses [6]